| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $955.2M | +25.8% |
| Cost of Revenue | $120.7M | +41.8% |
| Gross Profit | $834.5M | +23.8% |
| R&D Expense | $274.6M | +14.6% |
| SG&A Expense | $195.7M | +1.4% |
| Operating Income | -$70.5M | +50.6% |
| Pre-tax Income | -$48.1M | +44.0% |
| Income Tax | $10.5M | +113.7% |
| Net Income | -$56.0M | -784.5% |
| EPS (Basic) | -$0.34 | -750.0% |
| EPS (Diluted) | -$0.34 | -750.0% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $229.6M | +0.8% |
| Accounts Receivable | $304.3M | +15.0% |
| Current Assets | $1.66B | +23.9% |
| Total Assets | $1.72B | +23.1% |
| Current Liabilities | $652.1M | +19.7% |
| Total Liabilities | $686.5M | +18.8% |
| Stockholders' Equity | $990.7M | +27.7% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $232.9M | +464.0% |
| Capital Expenditures | $10.8M | +187.6% |
| Investing Cash Flow | -$267.3M | -776.5% |
| Financing Cash Flow | $34.8M | +6.7% |
| Free Cash Flow | $222.0M | +427.8% |